Healthcare Patients Pharmaceutical manufacturing Physicians 
Pharmaceutical Technology
SEPTEMBER 7, 2022
Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.
PM360
JUNE 26, 2023
Helpfully, Google conducted research to work out how healthcare professionals were sourcing products online. Despite physicians conducting an average of six professional searches every working day, only 17% of them searched with the words “pharmaceutical manufacturers.” Segment with pages dedicated to each audience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
AUGUST 12, 2022
In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. It also raises healthcare costs for public and private insurers alike.
pharmaphorum
OCTOBER 26, 2022
And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.
PM360
AUGUST 9, 2022
How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5
European Pharmaceutical Review
NOVEMBER 8, 2022
For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. Conclusion.
Impetus Digital
NOVEMBER 23, 2023
In these online programs, a handful of carefully selected KOLs attending the congress are asked to summarize abstracts that will be of special interest to other healthcare providers from their country/region or specialty. Some physicians still prefer to communicate via emails.
Expert insights. Personalized for you.
52 
Let's personalize your content